SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sartorius AG (SOAGY) trades at a trailing P/E of 127.1. Trailing earnings yield is 0.79%. PEG 1.60.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 127.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.79%).
- PEG Ratio 1.60 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 0.79% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 36/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SOAGY
Valuation Multiples
P/E (TTM)127.1
Forward P/EN/A
PEG Ratio1.60
Forward PEGN/A
P/B Ratio0.00
P/S Ratio5.55
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.43
Book Value / Share$0.00
Revenue / Share$9.84
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.79%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.30 |
$1.3B |
$102.93M |
7.9% |
| 2017 |
$0.06 |
$1.4B |
$114.73M |
8.2% |
| 2018 |
$0.07 |
$1.57B |
$141.34M |
9% |
| 2019 |
$0.08 |
$1.83B |
$156.69M |
8.6% |
| 2020 |
$0.10 |
$2.34B |
$210.1M |
9% |
| 2021 |
$1.25 |
$3.45B |
$318.9M |
9.2% |
| 2022 |
$2.67 |
$4.17B |
$678.1M |
16.2% |
| 2023 |
$0.60 |
$3.4B |
$205.2M |
6% |
| 2024 |
$0.24 |
$3.38B |
$84M |
2.5% |
| 2025 |
$0.43 |
$3.4B |
$148.79M |
4.4% |
